US 7348359
Retinoid X receptor modulators
granted A61PA61P13/08A61P13/10
Quick answer
US patent 7348359 (Retinoid X receptor modulators) held by Ligand Pharmaceuticals Incorporated expires Mon Mar 20 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Ligand Pharmaceuticals Incorporated
- Grant date
- Tue Mar 25 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 20 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 37
- CPC classes
- A61P, A61P13/08, A61P13/10, A61P17/00, A61P17/02